EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

YAP/TAZ: Molecular pathway and disease therapy

Yuzi Wei, Victoria Lee Zhi Hui, Yilin Chen, Ruiying Han, Xianglong Han, Yongwen Guo iD

MedComm · 2023-08 · 4 (4)

DOI: 10.1002/mco2.340 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 09.08.2023. Verfasst von Yuzi Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Sichuan University Ch…. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 418 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Yes‐associated protein and its transcriptional coactivator with PDZ‐binding motif (YAP/TAZ) are two homologous transcriptional coactivators that lie at the center of a key regulatory network of Hippo, Wnt, GPCR, estrogen, mechanical, and metabolism signaling. YAP/TAZ influences the expressions of downstream genes and proteins as well as enzyme activity in metabolic cycles, cell proliferation, inflammatory factor expression, and the transdifferentiation of fibroblasts into myofibroblasts. YAP/TAZ can also be regulated through epigenetic regulation and posttranslational modifications. Consequently, the regulatory function of these mechanisms implicates YAP/TAZ in the pathogenesis of metabolism‐related diseases, atherosclerosis, fibrosis, and the delicate equilibrium between cancer progression and organ regeneration. As such, there arises a pressing need for thorough investigation of YAP/TAZ in clinical settings. In this paper, we aim to elucidate the signaling pathways that regulate YAP/TAZ and explore the mechanisms of YAP/TAZ‐induce diseases and their potential therapeutic interventions. Furthermore, we summarize the current clinical studies investigating treatments targeting YAP/TAZ. We also address the limitations of existing research on YAP/TAZ and propose future directions for research. In conclusion, this review aims to provide fresh insights into the signaling mediated by YAP/TAZ and identify potential therapeutic targets to present innovative solutions to overcome the challenges associated with YAP/TAZ.

Schlagwörter

Stichwörter der Autor:innen

YAP/TAZatherosclerosiscancerfibrosismetabolismregeneration

Autor:innen und Institutionen

  • State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Sichuan University Chengdu Sichuan China.
  • Department of Orthodontics West China Hospital of Stomatology Sichuan University Chengdu Sichuan China.
  • Department of Orthodontics Lanzhou Stomatological Hospital Lanzhou Gansu China.

ORCID-Profile: Yongwen Guo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wei, Y., Hui, V. L. Z., Chen, Y., Han, R., Han, X., & Guo, Y. (2023). YAP/TAZ: Molecular pathway and disease therapy. MedComm, 4(4). https://doi.org/10.1002/mco2.340

Vancouver

Wei Y, Hui VLZ, Chen Y, Han R, Han X, Guo Y. YAP/TAZ: Molecular pathway and disease therapy. MedComm. 2023;4(4). doi:10.1002/mco2.340

BibTeX
@article{Wei2023,
  author = {Wei, Yuzi and Hui, Victoria Lee Zhi and Chen, Yilin and Han, Ruiying and Han, Xianglong and Guo, Yongwen},
  title = {YAP/TAZ: Molecular pathway and disease therapy},
  journal = {MedComm},
  year = {2023},
  volume = {4},
  number = {4},
  doi = {10.1002/mco2.340}
}
Kostenlos starten →